“LL-37”的搜索结果，显示 31-40 项，共有 6704 项

1. 血液科- 临床试验- 妙佑医疗国际

   ... 2). In Part 1, different level of step-up doses are tested followed by the target dose of ABBV-383. In Part 2, the step-up dose identified in Part 1 will be ...

2. 血液科- 临床试验- 妙佑医疗国际

   ... II dose (RP2D of APG2575 in combination with Pomalidomide/dexamethasone (Pd) in patients with relapsed/refractory (R/R) multiple myeloma (MM), or ...

3. 肺科- 临床试验- 妙佑医疗国际

   Go to page 22 · Go to page 33 · NextNext Page. 以下为当前的临床试验。 25 研究肺科（仅限开放性研究）. 按位置、状态和其他条件筛选该研究列表。 A Study To Evaluate ...

4. 肾病和高血压- 临床试验- 妙佑医疗国际

   Go to page 22 · Go to page 33 · Go to page 44. 以下为当前的临床试验。 37 研究肾病和高血压（仅限开放性研究）. 按位置、状态和其他条件筛选该研究列表。 REstrictive ...

5. 血液科- 临床试验- 妙佑医疗国际

   ... II dose (RP2D of APG2575 in combination with Pomalidomide/dexamethasone (Pd) in patients with relapsed/refractory (R/R) multiple myeloma (MM), or ...

6. 神经科- 临床试验- 妙佑医疗国际

   Cohort 3 includes (1) CMVpp65 absent and (2) CMVpp65 present GBM.. Patients in all subcohorts except 1.11 and 1.12 currently have unresectable advanced or ...

7. 神经科- 临床试验- 妙佑医疗国际

   ... 2 or 3 meningioma as measured by 6-month PFS rate. Mayo Clinic Cancer Center Neuro-Oncology Program Registry And Biobank For The Study Of Nervous System ...

8. 血液科- 临床试验- 妙佑医疗国际

   ... II dose (RP2D of APG2575 in combination with Pomalidomide/dexamethasone (Pd) in patients with relapsed/refractory (R/R) multiple myeloma (MM), or ...

9. 乳腺癌- 医生与科室- 妙佑医疗国际

   From fear to a phone call in 2 hours, breast cancer patient gets care faster with the help of intelligent automation. 显示更多来自妙佑医疗国际的新闻. 产品与 ...

10. 血液科- 临床试验- 妙佑医疗国际

    This phase II trial studies the effect of ascorbic acid and combination chemotherapy in treating patients with lymphoma that has come back (recurrent) or ...